The two principal classes of drugs targeting the prostate are -blockers and 5ARIs [9]. to sham group. The data of pBOO group expressed as folds
Structure-Based Design of mTORC1 Inhibitors in Cancer Therapy
mTORC1 inhibitor
mTORC1 inhibitor
The two principal classes of drugs targeting the prostate are -blockers and 5ARIs [9]. to sham group. The data of pBOO group expressed as folds